Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam R Winstock

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Addiction (Abingdon, England)|September 16, 2010
Legal highs and the challenges for policy makersAdam R Winstock, John D Ramsey
Journal of Psychopharmacology (Oxford, England)|November 5, 2019
Nitrous oxide causes peripheral neuropathy in a dose dependent manner among recreational usersAdam R Winstock, Jason A Ferris
Human Psychopharmacology|July 25, 2013
The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid productsAdam R Winstock, Monica J Barratt
Drug and Alcohol Dependence|July 4, 2002
4-MTA: a new synthetic drug on the dance sceneAdam R Winstock, Kim Wolff, John Ramsey
BMJ (Clinical Research Ed.)|March 25, 2010
What should be done about mephedrone?Adam R Winstock, John Marsden, Luke Mitcheson
BMJ (Clinical Research Ed.)|April 3, 2010
Assessment and management of cannabis use disorders in primary careAdam R Winstock, Chris Ford, John Witton
The International Journal on Drug Policy|August 10, 2014
Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug usersHanna Uosukainen, Ulrich Tacke, Adam R Winstock
Journal of Psychopharmacology (Oxford, England)|November 29, 2013
Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sampleAdam R Winstock, Stephen Kaar, Rohan Borschmann
The International Journal on Drug Policy|October 20, 2010
"Should I stay or should I go?" Coming off methadone and buprenorphine treatmentAdam R Winstock, Nicholas Lintzeris, Toby Lea
The International Journal on Drug Policy|March 25, 2008
Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, AustraliaAdam R Winstock, Toby Lea, Janie Sheridan
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Addiction (Abingdon, England)|September 16, 2010
Legal highs and the challenges for policy makersAdam R Winstock, John D Ramsey
Journal of Psychopharmacology (Oxford, England)|November 5, 2019
Nitrous oxide causes peripheral neuropathy in a dose dependent manner among recreational usersAdam R Winstock, Jason A Ferris
Human Psychopharmacology|July 25, 2013
The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid productsAdam R Winstock, Monica J Barratt
Drug and Alcohol Dependence|July 4, 2002
4-MTA: a new synthetic drug on the dance sceneAdam R Winstock, Kim Wolff, John Ramsey
BMJ (Clinical Research Ed.)|March 25, 2010
What should be done about mephedrone?Adam R Winstock, John Marsden, Luke Mitcheson
BMJ (Clinical Research Ed.)|April 3, 2010
Assessment and management of cannabis use disorders in primary careAdam R Winstock, Chris Ford, John Witton
The International Journal on Drug Policy|August 10, 2014
Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug usersHanna Uosukainen, Ulrich Tacke, Adam R Winstock
Journal of Psychopharmacology (Oxford, England)|November 29, 2013
Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sampleAdam R Winstock, Stephen Kaar, Rohan Borschmann
The International Journal on Drug Policy|October 20, 2010
"Should I stay or should I go?" Coming off methadone and buprenorphine treatmentAdam R Winstock, Nicholas Lintzeris, Toby Lea
The International Journal on Drug Policy|March 25, 2008
Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, AustraliaAdam R Winstock, Toby Lea, Janie Sheridan
Pageof 9